Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Launched by POWER LIFE SCIENCES INC. · Jan 12, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how and why patients with tardive dyskinesia get involved in clinical trials. Tardive dyskinesia is a condition that causes involuntary movements, often as a side effect of certain medications. Researchers want to understand the factors that influence patient participation and how to improve the process of recruiting and keeping participants in future studies. The results of this research will be shared at conferences and in medical papers to help make clinical trials more effective for everyone involved.

To be eligible for this trial, participants must be at least 18 years old, have a diagnosis of tardive dyskinesia, and should not have received any prior treatment for the condition. They also need to be able to provide written consent to participate. Unfortunately, individuals currently enrolled in another research study or those with certain psychiatric or substance abuse disorders may not be able to join. If you participate, you can expect to share your experiences and insights, which will ultimately help shape better clinical trials for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of tardive dyskinesia
• • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• • No prior treatment for tardive dyskinesia
• Exclusion Criteria:
• • Enrolled in another research study
• • Inability to provide written informed consent
• • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial